Ugro Capital GROx disburses ₹1,853 crore in Q1FY27
Ugro Capital reported Q1FY27 net profit of ₹607 million, up 78% YoY, fueled by GROx platform disbursements of ₹1,853 crore. Total net disbursements rose 59% to ₹2,551 crore. Asset quality strengthened with Gross Stage 3 ratios declining, and cost optimization efforts reduced operating expenses by 42%.

*this image is generated using AI for illustrative purposes only.
Ugro Capital reported a 78% year-on-year surge in standalone net profit to ₹607 million for Q1FY27, driven by the rapid scaling of its embedded merchant finance platform, GROx. The non-banking financial company (NBFC) recorded revenue from operations of ₹4.2 billion, up from ₹4.1 billion in the corresponding period last year. This performance marks the first full quarter of execution following the strategic realignment announced in February 2026, which shifted focus toward higher-yielding, scalable lending verticals.
GROx Drives Disbursement Growth
The technology-led embedded merchant finance platform, GROx (formerly MyShubhLife), emerged as the primary growth engine, disbursing ₹1,853 crore in the quarter alone. With over 60,000 loans disbursed monthly, GROx’s asset under management (AUM) grew 32% quarter-on-quarter to ₹3,003 crore as of June 30, 2026. The portfolio maintains strong asset quality with a gross non-performing asset (GNPA) ratio of 2.1% and a yield of approximately 26%. Across the company, total net disbursements rose 59% year-on-year to ₹2,551 crore.
| Metric: | Q1FY27 | Change |
|---|---|---|
| GROx Disbursements: | ₹1,853 crore | N/A |
| GROx AUM: | ₹3,003 crore | QoQ ↑ 32% |
| Total Net Disbursements: | ₹2,551 crore | YoY ↑ 59% |
Emerging Market Network Stabilizes
Ugro Capital completed the build-out of its Emerging Market branch network, now comprising 317 branches across 13 states supported by more than 2,500 employees. No further incremental branch investments are planned, with future growth expected from improved productivity. Branch productivity is projected to rise from ₹0.62 crore in Q1FY27 to ₹0.80–0.85 crore as the network matures. The Emerging Market business disbursed ₹592 crore, taking its AUM to ₹3,896 crore, up 9% quarter-on-quarter, with a GNPA of 2.1%.
Asset Quality and Profitability
Asset quality strengthened sequentially, with the Gross Stage 3 ratio declining to 2.75% from 3.66%, and the Net Stage 3 ratio improving to 1.71% from 2.24%. Overall GNPA remained stable at 2.6%. Profit Before Tax (PBT) increased 28% year-on-year to ₹61.5 crore. Return on Assets (ROA) improved to 2.8% from 2.1% in Q4FY26, while Return on Equity (ROE) rose to 9.2% from 7.1%. The company maintains a robust balance sheet with a Capital to Risk-Weighted Assets Ratio (CRAR) of 21.0% and cash reserves of ₹1,864 crore.
Strategic Realignment Progress
The company has fully achieved its planned ₹220 crore annualised cost optimisation, with quarterly operating expenses falling 42% to ₹118.5 crore. The lower-yielding Prime lending portfolio reduced by 14% during the quarter. Together, Emerging Market LAP and GROx now constitute 46% of the total AUM mix, up from 32% in December 2025, moving toward an 85% target by FY29. Ugro Capital expects no requirement for additional equity through FY29, aiming for a steady-state ROA of 3.0–3.5% by FY29.
What the Numbers Show
The divergence between stable total AUM (up 24% YoY to ₹15,013 crore) and surging profitability highlights the success of the portfolio mix shift. While overall AUM growth is moderate, the transition from lower-yield Prime loans to higher-yield GROx and Emerging Market loans has expanded margins significantly. The 42% drop in operating expenses alongside a 28% rise in PBT demonstrates that the cost optimization measures are directly translating into bottom-line gains, validating the shift toward an annuity-led earnings model.
Historical Stock Returns for UGRO Capital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.96% | -3.96% | -9.27% | -24.64% | -47.38% | -29.43% |
How might the aggressive shift toward higher-yield GROx and Emerging Market loans impact Ugro Capital's credit risk profile as it approaches its 85% AUM mix target by FY29?
With branch expansion halted, what specific operational strategies or technological interventions will Ugro Capital employ to achieve the projected jump in branch productivity from ₹0.62 crore to ₹0.85 crore?
Given the reliance on GROx for growth, how vulnerable is Ugro Capital to potential regulatory changes in the embedded finance or NBFC sector that could affect merchant lending practices?


































